Amir Emamifar, PharmD, MBA, Vice President and Chief Pharmacy Officer at Temple University Health System, shared five changes he would like to see in hospital pharmacy in 2022 with Becker’s Hospital Review.
800-TEMPLE-MED
Request Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Parth Rali Joins ReachMD to Discuss Findings From Real-World Propensity-Matched Analysis on Sotatercept Presented at ERS
Posted October 2, 2026
The analysis looked at sotatercept use in patients with pulmonary arterial hypertension and the safety and utilization across phenotype groups.
View DetailsMedscape Interviews Dr. Andrew Gangemi on His Research Presented at ERS Examining Two Objective Recommended Measures of COPD
Posted September 17, 2026
The mMRC and CAT are recommended for use to inform initial and long-term therapy, but both were developed and validated outside the United States with somewhat homogeneous populations.
View Details